James C. Hamilton, Chief Discovery/Trans Medicine at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 6,000 shares at $28.03 ($168K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Open-market sale of $168k ARWR by Chief Discovery/Trans Medicine. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARWR | SELL | 2026-01-05 | $2.5M | — | Filing → |
| ARWR | SELL | 2025-10-03 | $700K | — | Filing → |
| ARWR | SELL | 2025-09-16 | $450K | — | Filing → |